Piamkamon Vacharotayangul, D.D.S., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mouth Diseases | 1 | 2015 | 238 | 0.440 |
Why?
|
| Oral Medicine | 1 | 2024 | 36 | 0.230 |
Why?
|
| Burning Mouth Syndrome | 1 | 2024 | 25 | 0.230 |
Why?
|
| Papillomavirus Infections | 1 | 2015 | 1612 | 0.220 |
Why?
|
| Dental Care for Chronically Ill | 2 | 2013 | 32 | 0.210 |
Why?
|
| Cyclosporins | 1 | 2022 | 216 | 0.200 |
Why?
|
| Lichen Planus, Oral | 1 | 2022 | 56 | 0.190 |
Why?
|
| Thailand | 3 | 2015 | 288 | 0.170 |
Why?
|
| Mouth Neoplasms | 1 | 2024 | 593 | 0.160 |
Why?
|
| Precancerous Conditions | 1 | 2024 | 977 | 0.140 |
Why?
|
| Saliva, Artificial | 1 | 2015 | 4 | 0.130 |
Why?
|
| Xerostomia | 1 | 2015 | 94 | 0.130 |
Why?
|
| Dentists | 1 | 2013 | 177 | 0.100 |
Why?
|
| Diabetes Complications | 1 | 2015 | 1317 | 0.080 |
Why?
|
| Health Services Accessibility | 2 | 2024 | 5403 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2024 | 4023 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2013 | 3990 | 0.070 |
Why?
|
| Homosexuality, Male | 1 | 2015 | 1329 | 0.070 |
Why?
|
| Oral Health | 1 | 2012 | 486 | 0.070 |
Why?
|
| Health Services Needs and Demand | 1 | 2012 | 1401 | 0.060 |
Why?
|
| Leukoplakia, Oral | 1 | 2024 | 77 | 0.050 |
Why?
|
| HIV Infections | 3 | 2015 | 17275 | 0.050 |
Why?
|
| Paresthesia | 1 | 2024 | 162 | 0.050 |
Why?
|
| Fluocinonide | 1 | 2022 | 9 | 0.050 |
Why?
|
| Clobetasol | 1 | 2022 | 33 | 0.050 |
Why?
|
| Triamcinolone | 1 | 2022 | 68 | 0.050 |
Why?
|
| Prevalence | 2 | 2015 | 15646 | 0.050 |
Why?
|
| Genotype | 1 | 2015 | 12945 | 0.050 |
Why?
|
| Administration, Topical | 1 | 2022 | 697 | 0.040 |
Why?
|
| Tacrolimus | 1 | 2022 | 733 | 0.040 |
Why?
|
| Steroids | 1 | 2022 | 926 | 0.030 |
Why?
|
| Immunotherapy | 2 | 2024 | 4641 | 0.030 |
Why?
|
| Hypertension | 1 | 2015 | 8503 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2022 | 1927 | 0.030 |
Why?
|
| Dental Auxiliaries | 1 | 2013 | 9 | 0.030 |
Why?
|
| Refusal to Treat | 1 | 2013 | 45 | 0.030 |
Why?
|
| Dentist-Patient Relations | 1 | 2012 | 32 | 0.030 |
Why?
|
| Neoplasms | 1 | 2021 | 22030 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2021 | 1585 | 0.020 |
Why?
|
| Young Adult | 2 | 2015 | 58808 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 3840 | 0.020 |
Why?
|
| Humans | 9 | 2024 | 758381 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2022 | 3245 | 0.020 |
Why?
|
| Pain | 1 | 2024 | 5065 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 2850 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12721 | 0.020 |
Why?
|
| Male | 4 | 2024 | 358742 | 0.020 |
Why?
|
| Female | 4 | 2024 | 390316 | 0.020 |
Why?
|
| Perception | 1 | 2012 | 1196 | 0.020 |
Why?
|
| Adult | 2 | 2015 | 219916 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 3446 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2022 | 64379 | 0.010 |
Why?
|
| Quality of Life | 1 | 2024 | 13286 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2013 | 25953 | 0.010 |
Why?
|
| Self Report | 1 | 2012 | 3712 | 0.010 |
Why?
|
| Middle Aged | 3 | 2024 | 219560 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2024 | 54136 | 0.010 |
Why?
|
| United States | 1 | 2024 | 72140 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 58681 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 168217 | 0.000 |
Why?
|